Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > RE:Many questions - no answers
View:
Post by fossi_2002 on Feb 14, 2024 11:13am

RE:Many questions - no answers

If you don't believe CZO's development path could result in positive news why did you ever invest? Are your theatrics strictly performative?

What a stupid question!
We all invested here many years ago because we had a reliable basic business and believed that Gilles would be successful with at least one project.
That was not the case.
The only thing you do is repeat like a parrot everything Gilles puts in front of you. Thinking for yourself would be an advantage. But what can you expect when you get your "peanuts" in return.

Comment by prophetoffactz on Feb 14, 2024 11:37am
"We all invested here many years ago because we had a reliable basic business and believed that Gilles would be successful with at least one project." The base business is still there. Gilles said that after the adjustment year of 2023 growth should be back to historical trends. The Chair of AEZS said: Carolyn Egbert, Chair of Aeterna: “Ceapro has well-established and growing ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities